Prostate Cancer Screening Methods Are Shifting
Prostate cancer screening methods are shifting as medical providers increasingly use magnetic resonance imaging (MRI) to avoid unnecessary biopsies, according to a report from La Voix de l’Est.
While many prostate cancers are indolent and progress slowly, the disease remains the second most lethal cancer in Canada. Because it is common, many men die from it over their lives.
Medical practice has moved away from automatically performing biopsies when a patient shows an elevated prostate-specific antigen (PSA) level. Instead, clinicians now use MRI scans to better identify lesions.
“Si je me fie à la littérature, on estime que c’est à peu près 30 % à 40 % des hommes qui éviteront une biopsie grâce à l’imagerie par résonance magnétique (IRM),” said the report from La Voix de l’Est. When a biopsy is required, the imaging allows doctors to target specific areas rather than performing the procedure blindly.
Screening rates have declined in recent years following recommendations that family physicians offer testing only to men with adequate life expectancy who initiate the conversation.
A Canadian group is scheduled to review these clinical recommendations in 2027 to determine if changes are necessary.
For patients with advanced, metastatic prostate cancer, the condition remains incurable. However, prognosis has improved through the use of oral “super bloqueurs de testostérone” and chemotherapy. These treatments aim to deplete testosterone, which the cancer requires to grow, forcing the disease into dormancy.
Beyond clinical treatment, there is a push to improve support networks for patients and caregivers.
Dr. Patrick Richard said that the diagnostic process often carries a psychological stigma that requires better global management. Organizations such as Procure provide resources specifically for men, described by the report as being “Fait par des hommes, pour des hommes.”
During the recent month dedicated to men’s cancer awareness, the Sherbrooke-based group Unis contre le cancer de la prostate raised $123,015 to support the mission of Procure.
- How Indigenous Stewardship and Historical Ecology Can Guide Wildfire Recovery
- Three-Year-Old’s Metastatic Hepatoblastoma Reportedly Vanishes After Experimental CAR T-Cell Therapy
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
- SpaceX Dragon Returns Cancer Research Samples From ISS (time.news)